The KRAS and NRAS genes, variants of the RAS family, play a crucial role in CRC due to both their mutation frequency and their regulatory influence on pathways controlling cell proliferation, motility, angiogenesis, and survival. The gene discussed is KRAS; the disease is colorectal carcinoma.